Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc.（DCPH）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · DCPH · 截至 Jun 8, 2026
关键指标
探索 Deciphera Pharmaceuticals, Inc. 数据
dcph stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 26 · 买入占比: 50.0%
根据过去 3 个月内 26 位华尔街分析师，DCPH 共识评级为 Buy，12 个月平均目标价 $26.32 （较现价 $25.59 上涨空间 2.85%）。
竞争对手与同行
dcph competitorsDCPH
CALT
DICE
EMBC
FUSN
KDNY股票表现
完整历史关于 Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical firm focused on developing innovative therapies to significantly improve outcomes for cancer patients. Their core strategy involves tackling the …
what is deciphera pharmaceuticals, inc. · dcph stock overview · deciphera pharmaceuticals, inc. company profile · who is deciphera pharmaceuticals, inc. ceo · dcph NASDAQ · deciphera pharmaceuticals, inc. headquarters · deciphera pharmaceuticals, inc. business segments
关于股票概览与关键数据
Deciphera Pharmaceuticals, Inc.（DCPH）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Sep 28, 2017 在 NASDAQ 上市。截至最近交易日，DCPH 股价为 $25.59，市值约为 $2.2B。过去12个月累计回报 +86.92%，年初至今回报 +54.62%。
根据 26 位华尔街分析师，Deciphera Pharmaceuticals, Inc. 股票共识评级为Buy，12个月平均目标价为 $26.32。2023 财年 Deciphera Pharmaceuticals, Inc. 营收 $163.4M，净利润 -$194.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，Deciphera Pharmaceuticals, Inc.（DCPH）股价为 $25.59，在 NASDAQ 上市，52周区间为 $9.90 – $25.61。